PITX1 and chondrosarcoma: In summary, PITX1 may influence the development of CHS by modulating expression of the aforementioned immune checkpoints, which in turn affects the activity of T cells, B cells, and NK cells, leading to altered TICs and the development of immune evasion in chondrosarcoma.